Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Stackinstockson Dec 08, 2017 1:29pm

27 Views

Post# 27119042

RE:RE:RE:RE:RE:RE:RE:STACKINSTOCKS

Or you know.. I have been in for a while... never said I was proud of the trade

Not sure why you are even bothering though? You will never know the truth and people can say whatever they want here anyways.

For all you know I have a 10 million $ trading account or a $500 trading account. I could have bought 10,000 shares or 100,000 shares. I could be invested or not invested.

Keep speculating if it gives you enjoyment.

Bullboard Posts

Covalon Technologies posts third profitable quarter in a row